Related Experiment Videos
Fluoxetine for the treatment of social phobia
Journal of Clinical Psychopharmacology
|August 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Risk and Protective Factors for Well-being and Barriers to Help-Seeking Among Arab-Speaking MENA Immigrants and Refugees in North America: A Scoping Review.
Global social welfare : research, policy & practice·2025
A revised lower estimate of ozone columns during Earth's oxygenated history.
Royal Society open science·2022
SU-E-J-37: Radiation Dose during Chemoembolization: A Predictive Model.
Medical physics·2017
Describing readmissions to an Ebola case management centre (CMC), Sierra Leone, 2014.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2014
Low-Dose Clozapine Versus Aripiprazole in Borderline Personality Disorder: A Prospective Naturalistic Study.
Journal of clinical psychopharmacology·2026
Efficacy and Tolerability of Zonisamide for Alcohol Use Disorder: A Systematic Review and Meta-Analysis.
Journal of clinical psychopharmacology·2026
The Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression: A Phase IIa Proof-of-Concept Clinical Trial.
Journal of clinical psychopharmacology·2026
The Randomization Effect in a Double-Blind Placebo-Controlled Depression Study.
Journal of clinical psychopharmacology·2026
Memantine Augmentation for Obsessive-Compulsive Symptoms in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
Journal of clinical psychopharmacology·2026
Partial Dopamine Agonists and Gambling Disorder: A Comprehensive Review and Clinical Implications.
Journal of clinical psychopharmacology·2026
The role of genetic explanations of substance use disorders in shaping stigma in the general public.
European addiction research·2026
Perspectives on the use of lithium as a therapeutic option for bipolar disorder in 2026.
Expert review of neurotherapeutics·2026